Exploring the potential function of high expression of ANAPC1 in regulating ubiquitination in hepatocellular carcinoma

Figure 1 The main analysis flow chart of this study. HCC: Hepatocellular carcinoma; mRNA: Messenger RNA; scRNA-seq: Single-cell RNA sequencing; SROC: Synthetic receiver operating characteristic; UMAP: Uniform manifold approximation and projection; NK: Natural killer; MIF: Migration inhibitory factor; MK: Midkine; VISFATIN: Visfatin; SPP1: Secreted phosphoprotein 1; PARs: Protease-activated receptors; ANGPTL: Angiopoietin-like protein; GALECTIN: Galactoside-binding lectin; CXCL: Chemokine (C-X-C motif) ligand; COMPLEMENT: Complement system proteins; PTN: Pleiotrophin; CCL: Chemokine (C-C motif) ligand; VEGF: Vascular endothelial growth factor; CALCR: Calcitonin receptor; ANNEXIN: Annexin; GDF: Growth differentiation factor; GAS: Growth arrest-specific 6; PROS: Protein S; ANGPT: Angiopoietin; PSAP: Prosaposin; BAFF: B cell activating factor; EGF: Epidermal growth factor; PDGF: Platelet-derived growth factor; IL16: Interleukin 16; FGF: Fibroblast growth factor; PERIOSTIN: Periostin.